BioNTech SE ADR (NASDAQ: BNTX) is -4.65% lower on its value in year-to-date trading and has touched a low of $76.53 and a high of $119.78 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BNTX stock was last observed hovering at around $100.53 in the last trading session, with the day’s gains setting it 0.1%.
Currently trading at $100.63, the stock is 14.36% and 18.52% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.65 million and changing 0.10% at the moment leaves the stock 8.71% off its SMA200. BNTX registered -16.23% loss for a year compared to 6-month loss of 4.50%.
The stock witnessed a 24.54% gain in the last 1 month and extending the period to 3 months gives it a 2.70%, and is 14.35% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.46% over the week and 3.60% over the month.
BioNTech SE ADR (BNTX) has around 3082 employees, a market worth around $23.92B and $2.91B in sales. Profit margin for the company is -18.73%. Distance from 52-week low is 31.49% and -15.99% from its 52-week high. The company has generated returns on investments over the last 12 months (-2.63%).
with sales reaching $663.49M over the same period.The EPS is expected to shrink by -159.90% this year, but quarterly earnings will post -27.50% year-over-year.
BioNTech SE ADR (BNTX) Top Institutional Holders
The shares outstanding are 237.73M, and float is at 237.11M with Short Float at 1.31%.
The top institutional shareholder in the company is BAILLIE GIFFORD & CO with over 8.28 million shares valued at $665.08 million. The investor’s holdings represent 3.4408% of the BNTX Shares outstanding. As of 2024-06-30, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 4.79 million shares valued at $384.89 million to account for 1.9912 of the shares outstanding. The other top investors are FLOSSBACH VON STORCH AG which holds 4.38 million shares representing 1.8207% and valued at over $351.94 million, while HARDING LOEVNER LP holds 1.2168 of the shares totaling 2.93 million with a market value of $235.22 million.
BioNTech SE ADR (BNTX) Insider Activity
#####
